Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Healthcare
Zenas BioPharma, Inc. Long Term Debt 2023–2025
Zenas BioPharma, Inc. annual/quarterly long term debt history from 2025 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Zenas BioPharma, Inc. long term debt for the quarter ending December 31, 2025 were 78.6M.
- Zenas BioPharma, Inc. long term debt for 2025 were 78.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zenas BioPharma, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $79 |
| Zenas BioPharma, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $79 |
Zenas BioPharma, Inc. Long Term Debt — FAQ
Zenas BioPharma, Inc. (ZBIO) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZBIO's long term debt history?
The chart and table above show Zenas BioPharma, Inc.'s long term debt by year and by quarter, including the growth rate.